A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Public ClinicalTrials.gov record NCT01472198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine as First Line Treatment for Metastatic Pancreatic Adenocarcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the efficacy of simtuzumab (GS-6624) versus placebo in combination with gemcitabine in adults with pancreatic cancer. The treatment phase of this study will be comprised of 2 sequential parts: an open label treatment phase and a double-blinded treatment phase.
Study identification
- NCT ID
- NCT01472198
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2011 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Feb 2015 (Actual)
- Last update posted
- Mar 10, 2015
2011 – 2015
United States locations
- U.S. sites
- 44
- U.S. states
- 23
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology and Oncology Associates, LLC | Birmingham | Alabama | — | — |
| University of South Alabama Mitchell Cancer Institute | Mobile | Alabama | 36604 | — |
| Central Hematology Oncology Medical Group, Inc. | Alhambra | California | — | — |
| Comprehensive Blood and Cancer Center | Bakersfield | California | — | — |
| California Cancer Associates for Research and Excellence (CCARE) | Fresno | California | 93720 | — |
| Pacific Shores Medical Group | Long Beach | California | — | — |
| UCLA Community Oncology Practice | Los Angeles | California | — | — |
| Stanford University Medical Center | Palo Alto | California | — | — |
| Wilshire Oncology Medical Group, Inc. | Rancho Cucamonga | California | 91730 | — |
| Sharp Health Care | San Diego | California | 92123 | — |
| San Jose Medical Group | San Jose | California | 95116 | — |
| Saint Mary's Regional Cancer Center | Grand Junction | Colorado | — | — |
| Hematology Oncology Associates, PC | Stamford | Connecticut | — | — |
| Florida Cancer Specialists | Tampa | Florida | 33607 | — |
| Georgia Cancer Specialists, P.C. | Atlanta | Georgia | 30341 | — |
| Northwestern University | Chicago | Illinois | — | — |
| Oncology Hematology Care, Inc. | Crestview Hills | Kentucky | 41017 | — |
| Anne Arundel Medical Center, Annapolis Oncology Center | Annapolis | Maryland | — | — |
| West Michigan Cancer Center | Kalamazoo | Michigan | — | — |
| Providence Cancer Center Oncology and Hematology Care Clinic-Eastside Portland | Southfield | Michigan | 48075 | — |
| Hematology and Oncology Associates at BridgePoint | Tupelo | Mississippi | — | — |
| Saint Joseph Oncology, Inc. | Saint Joseph | Missouri | — | — |
| Washington University School of Medicine | St Louis | Missouri | 63108 | — |
| Montana Cancer Institute Foundation c/o Montana Cancer Specialists | Missoula | Montana | — | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | — | — |
| Saint Luke's-Roosevelt Hospital Center | New York | New York | 10003 | — |
| Beth Israel Comprehensive Cancer Center | New York | New York | — | — |
| Duke University Medical Center, Comprehensive Cancer Center | Durham | North Carolina | — | — |
| Emerywood Hematology and Oncology | High Point | North Carolina | — | — |
| Oncology Hematology Care, Inc. | Blue Ash | Ohio | 45242 | — |
| PinnacleHealth | Harrisburg | Pennsylvania | 17109 | — |
| Abington Hematology Oncology Associates, Inc. | Willow Grove | Pennsylvania | 19090 | — |
| Charleston Hematology Oncology Associates, PA | Charleston | South Carolina | — | — |
| South Carolina Oncology Associates | Columbia | South Carolina | — | — |
| Tennessee Cancer Specialists | Knoxville | Tennessee | — | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37206 | — |
| Coastal Bend Cancer Center | Corpus Christi | Texas | — | — |
| University of Texas Southwestern Medical Center at Dallas | Dallas | Texas | — | — |
| San Antonio Military Medical Center | Fort Sam Houston | Texas | 78234 | — |
| Center for Cancer and Blood Disorders, PC | Fort Worth | Texas | — | — |
| Joe Arrington Cancer Research and Treatment Center | Lubbock | Texas | — | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | — | — |
| Virginia Cancer Institute | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01472198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2015 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01472198 live on ClinicalTrials.gov.